After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More

255
21
Favorite

After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More

StreetInsider2022-02-14

After-Hours Stock Movers:

Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.

Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.

Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.

Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.

Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.

Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.

Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

255

Report

Comment（21）

romanc9
·2022-02-15
Interesting
Reply
1
Report
Steven Tay
·2022-02-15
Noted
Reply
1
Report
LuckyPiggie
·2022-02-15
Stock to the heart ... im too late . You give lub a bad name Valentine celebration
Reply
2
Report
ProsperTTM
·2022-02-15
Noted
Reply
1
Report
SanWangtikup
·2022-02-15
Good
Reply
2
Report
seojun
·2022-02-15
More news!!!
Reply
2
Report
Elsontok
·2022-02-15
like please
Reply
6
Report
Fold Replies
- seojun:
  done
  2022-02-15
  Reply
  Report
SCLIEW
·2022-02-15
666
Reply
3
Report
HongYu95
·2022-02-15

Reply
3
Report
WaiSiong81
·2022-02-15
👍
Reply
3
Report
time to eat
·2022-02-15
Just buy
Reply
6
Report
Fold Replies
- saral:
  Like
  2022-02-15
  Reply
  Report
- Bentofighter:
  Ok
  2022-02-15
  Reply
  Report
BGTAN
·2022-02-14
Ok
Reply
4
Report
Fold Replies
- Linda1127:
  good
  2022-02-15
  Reply
  Report
DDPang
·2022-02-14
Like!
Reply
9
Report
Fold Replies
- BGTAN:
  ok
  2022-02-14
  Reply
  Report
- ALAL:
  yea
  2022-02-15
  Reply
  Report
Karenchong
·2022-02-14
Great!
Reply
5
Report
SP1980
·2022-02-14
Gogogo
Reply
4
Report
Fold Replies
- SP1980:
  gogogo
  2022-02-14
  Reply
  Report
vSup_puSv
·2022-02-14
Like pls
Reply
7
Report
Ytyt
·2022-02-14
Pls like
Reply
9
Report
KCKHOO
·2022-02-14
👍
Reply
5
Report
Oyh
·2022-02-14
Ok
Reply
2
Report
Oyh
·2022-02-14
Ok
Reply
1
Report

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2211950054?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2022-02-15 07:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2211950054","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","media":"StreetInsider","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LRMR","symbol_name":"Larimar Therapeutics, Inc.","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","article_id":"2211950054","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","pubTimestamp":1644881063,"columns":[],"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"translate_title":"下班后股票搬运工：塔半导体、Amkor、Arista、Larimar、Monster Beverage等","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMKR":1,"ANET":1,"INTU":1,"LRMR":1,"OMCL":1,"TSEM":1},"content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[{"id":9095623275,"gmtCreate":1644901238274,"gmtModify":1676533974008,"author":{"id":"4102495020619380","authorId":"4102495020619380","name":"romanc9","avatar":"https://static.tigerbbs.com/76bfe37245defa055adfff7453f1520f","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":1,"idStr":"4102495020619380","authorIdStr":"4102495020619380"},"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095623275","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095663730,"gmtCreate":1644898630422,"gmtModify":1676533973760,"author":{"id":"4099285253763630","authorId":"4099285253763630","name":"Steven Tay","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"4099285253763630","authorIdStr":"4099285253763630"},"htmlText":"Noted&nbsp;","listText":"Noted&nbsp;","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095663730","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095681633,"gmtCreate":1644895990686,"gmtModify":1676533973517,"author":{"id":"4107063207857540","authorId":"4107063207857540","name":"LuckyPiggie","avatar":"https://community-static.tradeup.com/news/33330ac1fe6d6c956e10045c870d6f46","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":6,"crmLevelSwitch":1,"idStr":"4107063207857540","authorIdStr":"4107063207857540"},"htmlText":"Stock to the heart ... im too late . You give lub a bad name&nbsp;[Sly]&nbsp;[LOL]&nbsp;&nbsp;Valentine celebration&nbsp;","listText":"Stock to the heart ... im too late . You give lub a bad name&nbsp;[Sly]&nbsp;[LOL]&nbsp;&nbsp;Valentine celebration&nbsp;","text":"Stock to the heart ... im too late . You give lub a bad name [Sly] [LOL] Valentine celebration","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095681633","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095610344,"gmtCreate":1644892828477,"gmtModify":1676533972957,"author":{"id":"3575786148063178","authorId":"3575786148063178","name":"ProsperTTM","avatar":"https://community-static.tradeup.com/news/564b675883a4f5ee38c61806dba7ae3e","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":5,"crmLevelSwitch":1,"idStr":"3575786148063178","authorIdStr":"3575786148063178"},"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095610344","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095871580,"gmtCreate":1644887241363,"gmtModify":1676533972062,"author":{"id":"4087452914358580","authorId":"4087452914358580","name":"SanWangtikup","avatar":"https://static.tigerbbs.com/c7f061d50a9f915d0ce8e8c879871960","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":0,"idStr":"4087452914358580","authorIdStr":"4087452914358580"},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095871580","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095844952,"gmtCreate":1644886355138,"gmtModify":1676533971923,"author":{"id":"4087771643270940","authorId":"4087771643270940","name":"seojun","avatar":"https://static.tigerbbs.com/3bd9ce06b0a58d0a81582641f6566970","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"4087771643270940","authorIdStr":"4087771643270940"},"htmlText":"More news!!!","listText":"More news!!!","text":"More news!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095844952","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095841982,"gmtCreate":1644885935916,"gmtModify":1676533971700,"author":{"id":"3577246510298951","authorId":"3577246510298951","name":"Elsontok","avatar":"https://static.tigerbbs.com/5d91c4e73ceffea4b93c2c832535db3b","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3577246510298951","authorIdStr":"3577246510298951"},"htmlText":"like please","listText":"like please","text":"like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9095841982","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":100539922,"gmtCreate":1644886360403,"gmtModify":1663243807838,"authorId":4087771643270940,"author":{"id":4087771643270940,"idStr":"4087771643270940","authorId":4087771643270940,"name":"seojun","avatar":"https://static.tigerbbs.com/3bd9ce06b0a58d0a81582641f6566970","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9095841982,"type":1,"supId":0,"prevId":0,"content":"done","text":"done","html":"done"}],"langContent":"EN"},{"id":9095855967,"gmtCreate":1644885286501,"gmtModify":1676533971580,"author":{"id":"4092970777728640","authorId":"4092970777728640","name":"SCLIEW","avatar":"https://static.tigerbbs.com/5da553e4d3d35db75d1caae023ca8a03","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4092970777728640","authorIdStr":"4092970777728640"},"htmlText":"666","listText":"666","text":"666","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095855967","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095852965,"gmtCreate":1644885173514,"gmtModify":1676533971556,"author":{"id":"3575634917848634","authorId":"3575634917848634","name":"HongYu95","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":6,"crmLevelSwitch":0,"idStr":"3575634917848634","authorIdStr":"3575634917848634"},"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095852965","repostId":2211950054,"repostType":2,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095859869,"gmtCreate":1644884712463,"gmtModify":1676533971449,"author":{"id":"4092698747642690","authorId":"4092698747642690","name":"WaiSiong81","avatar":"https://static.tigerbbs.com/81c10c8d3ad2387a719eaa62a541371f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4092698747642690","authorIdStr":"4092698747642690"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095859869","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095829132,"gmtCreate":1644883698613,"gmtModify":1676533971237,"author":{"id":"3583412008066274","authorId":"3583412008066274","name":"time to eat","avatar":"https://static.tigerbbs.com/c3d6a537cecde2d1daeefa1dd8ff6f99","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3583412008066274","authorIdStr":"3583412008066274"},"htmlText":"Just buy","listText":"Just buy","text":"Just buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9095829132","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":100539239,"gmtCreate":1644884020738,"gmtModify":1663243806029,"authorId":3568944508199908,"author":{"id":3568944508199908,"idStr":"3568944508199908","authorId":3568944508199908,"name":"saral","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9095829132,"type":1,"supId":0,"prevId":0,"content":"Like","text":"Like","html":"Like"},{"id":100539441,"gmtCreate":1644884737048,"gmtModify":1644884737048,"authorId":3583478720415511,"author":{"id":3583478720415511,"idStr":"3583478720415511","authorId":3583478720415511,"name":"Bentofighter","avatar":"https://static.tigerbbs.com/3d3b444e1397cd8d1ec1b18c5c8c5db5","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.17","exceedPercentage":"93.30%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9095829132,"type":1,"supId":100539239,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":9095866882,"gmtCreate":1644883032391,"gmtModify":1676533970958,"author":{"id":"3578630064980119","authorId":"3578630064980119","name":"BGTAN","avatar":"https://static.tigerbbs.com/8ca7305b1f6bd1d4dd9abf3c54e6fbdb","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":1,"idStr":"3578630064980119","authorIdStr":"3578630064980119"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9095866882","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":100539404,"gmtCreate":1644884646846,"gmtModify":1644884646846,"authorId":4091084014142520,"author":{"id":4091084014142520,"idStr":"4091084014142520","authorId":4091084014142520,"name":"Linda1127","avatar":"https://community-static.tradeup.com/news/e698ee2dfbe4632bdd606a5fcfe89d5e","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.17","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9095866882,"type":1,"supId":0,"prevId":0,"content":"<u>good</u>","text":"<u>good</u>","html":"<u>good</u>"}],"langContent":"EN"},{"id":9095863472,"gmtCreate":1644882660817,"gmtModify":1676533970928,"author":{"id":"4100170711003780","authorId":"4100170711003780","name":"DDPang","avatar":"https://static.tigerbbs.com/4184fedc9dc315435a6c00f790c718f4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4100170711003780","authorIdStr":"4100170711003780"},"htmlText":"Like![Heart]&nbsp;","listText":"Like![Heart]&nbsp;","text":"Like![Heart]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9095863472","repostId":2211950054,"repostType":2,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":100538875,"gmtCreate":1644883027802,"gmtModify":1663243804235,"authorId":3578630064980119,"author":{"id":3578630064980119,"idStr":"3578630064980119","authorId":3578630064980119,"name":"BGTAN","avatar":"https://static.tigerbbs.com/8ca7305b1f6bd1d4dd9abf3c54e6fbdb","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.10","exceedPercentage":"80.82%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9095863472,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":100539125,"gmtCreate":1644883638165,"gmtModify":1644883638165,"authorId":3573967796529092,"author":{"id":3573967796529092,"idStr":"3573967796529092","authorId":3573967796529092,"name":"ALAL","avatar":"https://static.tigerbbs.com/875b16da8a8772902d1aaf69f6c0d98a","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9095863472,"type":1,"supId":0,"prevId":0,"content":"yea","text":"yea","html":"yea"}],"langContent":"EN"},{"id":9095860593,"gmtCreate":1644882502324,"gmtModify":1676533970853,"author":{"id":"4091885303412670","authorId":"4091885303412670","name":"Karenchong","avatar":"https://static.tigerbbs.com/4ff04417647dcd5364cd2022b9afccf1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4091885303412670","authorIdStr":"4091885303412670"},"htmlText":"Great!","listText":"Great!","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095860593","repostId":2211950054,"repostType":2,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095884390,"gmtCreate":1644882171219,"gmtModify":1676533970813,"author":{"id":"3573379860144244","authorId":"3573379860144244","name":"SP1980","avatar":"https://static.tigerbbs.com/101a00da82e124351de89d6d885f76b9","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":1,"idStr":"3573379860144244","authorIdStr":"3573379860144244"},"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9095884390","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":100538621,"gmtCreate":1644882180464,"gmtModify":1663243804045,"authorId":3573379860144244,"author":{"id":3573379860144244,"idStr":"3573379860144244","authorId":3573379860144244,"name":"SP1980","avatar":"https://static.tigerbbs.com/101a00da82e124351de89d6d885f76b9","vip":1,"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9095884390,"type":1,"supId":0,"prevId":0,"content":"gogogo","text":"gogogo","html":"gogogo"}],"langContent":"EN"},{"id":9095885719,"gmtCreate":1644882134034,"gmtModify":1676533970782,"author":{"id":"3581550492242446","authorId":"3581550492242446","name":"vSup_puSv","avatar":"https://static.tigerbbs.com/a1150421a148787160d999c5a94bed8e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581550492242446","authorIdStr":"3581550492242446"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095885719","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095885220,"gmtCreate":1644882104581,"gmtModify":1676533970781,"author":{"id":"4094269572113460","authorId":"4094269572113460","name":"Ytyt","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4094269572113460","authorIdStr":"4094269572113460"},"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095885220","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095881432,"gmtCreate":1644881783252,"gmtModify":1676533970669,"author":{"id":"4097285050099240","authorId":"4097285050099240","name":"KCKHOO","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4097285050099240","authorIdStr":"4097285050099240"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095881432","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095881134,"gmtCreate":1644881693162,"gmtModify":1676533970654,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://community-static.tradeup.com/news/6efe76978b8678e18a4d96fd589746dd","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095881134","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9095883536,"gmtCreate":1644881619459,"gmtModify":1676533970630,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://community-static.tradeup.com/news/6efe76978b8678e18a4d96fd589746dd","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095883536","repostId":2211950054,"repostType":4,"repost":{"id":"2211950054","kind":"news","pubTimestamp":1644881063,"share":"https://ttm.financial/m/news/2211950054?lang=&edition=full_marsco","pubTime":"2022-02-15 07:24","market":"us","language":"en","title":"After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2211950054","media":"StreetInsider","summary":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback fr","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/LRMR\">Larimar Therapeutics, Inc.</a> (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.</p><p><a href=\"https://laohu8.com/S/TWR.AU\">Tower</a> Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.</p><p>Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.</p><p>Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.</p><p><a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.</p><p>Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.</p><p>Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Tower Semiconductor, Amkor, Arista,Larimar,Monster Beverage and More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19620201><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19620201\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","TSEM":"Tower半导体","BK4023":"应用软件","ANET":"Arista Networks, Inc.","BK4139":"生物科技","BK4554":"元宇宙及AR概念","AMKR":"艾马克技术公司","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4141":"半导体产品","INTU":"财捷","BK4167":"医疗保健技术","BK4147":"半导体设备","BK4534":"瑞士信贷持仓","BK4020":"通信设备","BK4528":"SaaS概念","OMCL":"Omnicell","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19620201","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211950054","content_text":"After-Hours Stock Movers:Larimar Therapeutics, Inc. (Nasdaq: LRMR) 55.3% LOWER; received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimars CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agencys request.Tower Semiconductor (NASDAQ: TSEM) 50% HIGHER; Intel (NASDAQ: INTC) is nearing a deal to acquire Tower Semiconductor (NASDAQ: TSEM), according to Dow Jones, citing sources. The deal is for roughly $6 billion.Amkor Technology (NASDAQ: AMKR) 8.5% HIGHER; reported Q4 EPS of $0.88, versus $0.52 reported last year. Revenue for the quarter came in at $1.72 billion, versus $1.37 billion reported last year.Arista Networks (NYSE: ANET) 8.3% HIGHER; reported Q4 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $824.5 million versus the consensus estimate of $786.46 million. Arista Networks sees Q1 2022 revenue of $840-860 million, versus the consensus of $831.6 million.Omnicell (NASDAQ: OMCL) 4.5% LOWER; reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million. Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million. Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.Monster Beverage (NASDAQ: MNST) 2.9% HIGHER; Talks between Monster Beverage and Constellation Brands (NYSE: STZ) about a combination are progressing, according to Bloomberg, citing people with knowledge of the matter.Intuit Inc. (Nasdaq: INTU) 2.2% LOWER; Expects Q2 Revenue to Reflect Slower Forming Tax Season","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":255,"commentSize":21,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}